The SoCal Edge

Art Dicker and Alessandro Rinaldi

A podcast about the practical decisions behind growing a business in Southern California — capital, hiring, partnerships, exits, and leadership.

  1. 1d ago

    Before You Sell: Building a Business Private Equity Wants to Buy

    What makes a business truly ready to sell? And why should founders start thinking about an exit years before they actually want one? In this episode of The SoCal Edge, Art Dicker sits down with Shaaya Sharifi, founder and CEO of Isle Ventures, to discuss how founders can build enterprise value and prepare their companies for a successful exit. Drawing on his experience in private equity, venture-backed companies, operating roles, and M&A, Shaaya explains how sophisticated buyers evaluate founder-led businesses—and why uncertainty almost always gets priced as risk. The conversation covers the practical work that can make a company more attractive to private equity and strategic buyers, including cleaning up financial reporting, reducing owner dependency, strengthening the management team, improving revenue quality, addressing customer concentration, organizing contracts and diligence materials, and building a compelling growth story. Shaaya also explains the differences between how private equity firms and strategic acquirers evaluate opportunities, why deal terms can matter as much as headline valuation, and how founders can think about the right buyer in terms of employees, customers, legacy, and cultural fit. The key takeaway: exit readiness shouldn't begin when you're ready to sell. Building a company with enterprise value and transferability in mind creates optionality...whether the eventual outcome is a sale, recapitalization, growth investment, or something else.

    Before You Sell: Building a Business Private Equity Wants to Buy
  2. Sep 10

    From UCSD Lab to Medtech Startup: Sai Zhou on the Future of Wearable Ultrasound

    What if an ultrasound machine could become small enough to wear—and continuously monitor what’s happening inside the body? In this episode of The SoCal Edge, Art Dicker sits down with Sai Zhou, founder and CEO of CircuCare, a San Diego medtech startup developing wearable ultrasound technology. Sai traces his journey from studying materials science in China to biomedical engineering research at UC San Diego, where he worked on making traditional ultrasound technology dramatically smaller, thinner, and potentially usable beyond hospitals and clinics. Sai explains why CircuCare is initially focused on echocardiography and cardiovascular monitoring, and how wearable ultrasound could offer something existing consumer wearables cannot: the ability to continuously image the heart itself. He also discusses the challenge of turning breakthrough academic research into a durable, user-friendly medical device that can ultimately navigate the FDA process. The conversation also explores the much broader potential of wearable ultrasound—from fetal and lung monitoring to pain management, neuromodulation and even powering implanted devices. Finally, Sai shares how UC San Diego’s research, medical and entrepreneurial ecosystem helped him make the leap from researcher to founder—and why Southern California has become such an important ecosystem for building medtech companies. Reach out to Sai: https://www.linkedin.com/in/-saizhou/ Learn more about CircuCare: https://www.circucare.com/

    From UCSD Lab to Medtech Startup: Sai Zhou on the Future of Wearable Ultrasound
  3. Sep 1

    Inside the Private Equity Playbook: Getting Your Company Financially Ready

    What happens when a growing company outgrows its bookkeeper—but isn’t ready for a full-time CFO? How does having a private equity owner change how management looks at the financials? In this episode of The SoCal Edge, Art Dicker sits down with Erin Ludwig, founding partner of Blue Bird Partners, a fractional CFO firm focused on founder-owned and private-equity-backed technology companies. Erin explains the financial infrastructure growing businesses need as they move from simply making money to making strategic decisions about where the company is headed. She discusses the numbers founders should actually be watching, including cash flow, forecasts, budgets, industry-specific KPIs, and the 13-week cash flow forecast that can give owners much better visibility into what lies ahead. The conversation also explores when a company needs a controller or fractional CFO, what private equity investors expect from financial reporting, and why preparing for an eventual sale should begin well before a buyer shows up. Erin explains how weak financial systems can create problems during due diligence—and potentially translate into discounts to a company’s expected valuation. Erin shares her perspective on Orange County and Southern California’s growing entrepreneurial ecosystem and the opportunities she sees among founder-led and lower-middle-market businesses throughout the region. For founders thinking about scaling, raising capital, bringing in institutional investors, or eventually selling their company, this episode is a practical look at how better financial visibility can help turn growth into long-term value.

    Inside the Private Equity Playbook: Getting Your Company Financially Ready
  4. May 13

    Why Founders Leave Millions on the Table When Selling Their Company

    In this episode of SoCal Edge, we sit down with technology and business transformation leaders Elisa Henry and Allen Kim to explore what founders should really be doing 18–24 months before trying to sell their company. Drawing on decades of experience in technology, AI, product management, and operational scaling, Elisa and Allen explain why many founders leave millions on the table during an acquisition process — often because the business is too dependent on the founder, lacks scalable systems, or has hidden technical and operational debt. The conversation dives into what sophisticated buyers and private equity firms are actually looking for during due diligence, including: Why “service businesses disguised as product companies” often receive dramatically lower valuationsHow recurring revenue and customer stickiness can significantly increase multiplesThe role of technical debt, legacy systems, and AI in modern M&A preparationWhy documenting processes and building a strong data room early can make or break a dealHow founders can reduce dependency on themselves before an exitThe importance of leadership development and aligning employee incentives during a sale processHow AI tools are accelerating due diligence and exposing operational weaknesses faster than ever beforeCommon mistakes founders make when trying to prepare for an acquisition too lateElisa and Allen also share practical insights from working alongside founders through emotionally difficult transitions, helping companies move from founder-led organizations into scalable, acquisition-ready businesses. If you’re a founder, executive, investor, or advisor thinking about growth, scalability, or eventual exit planning, this episode offers a highly practical look inside the realities of preparing a company for sale. #podcast #business #startup #AI #MandA #founders #technology #privateequity #entrepreneurship #SoCalEdge Connect with Elisa and Allen: https://www.linkedin.com/in/henryelisa/https://www.linkedin.com/in/allenwkim/

    Why Founders Leave Millions on the Table When Selling Their Company
  5. May 7

    Rethinking Breast Cancer Treatment, with MeCo Diagnostics CEO Adam Watson

    In this episode of SoCal Edge, we sit down with Adam Watson, co-founder and CEO of MeCo Diagnostics, a San Diego-based biotech startup developing the only clinically validated biomarker test designed to match breast cancer patients with anti-fibrotic therapy. Adam shares the remarkable journey from cancer biology PhD student to startup founder, explaining how his dissertation research evolved into a venture-backed company aiming to unlock what he describes as a “seventh modality” of breast cancer treatment. The conversation explores how MeCo Diagnostics is taking an unconventional approach to oncology by repurposing existing anti-fibrotic drugs rather than developing entirely new therapies — with the potential to dramatically reduce both cancer recurrence and treatment costs. We also dive into: Why the economics of cancer treatment are becoming unsustainableThe challenges of fundraising as a diagnostics companyHow biotech founders tailor pitches differently for VCs, angels, and family officesThe realities of leaving academia and becoming a first-time CEOLessons learned from building a biotech startup with limited capitalThe role EvoNexus and the San Diego biotech ecosystem played in the company’s growthFounder loneliness, impostor syndrome, and the pressures of startup lifeWhy Adam believes many people underestimate how difficult entrepreneurship really isThis episode offers a candid look at the intersection of biotech innovation, healthcare economics, and startup building — from someone trying to fundamentally rethink how cancer care is delivered. Reach out to Adam: https://www.linkedin.com/in/adam-watson-phd/

    Rethinking Breast Cancer Treatment, with MeCo Diagnostics CEO Adam Watson

Ratings & Reviews

5
out of 5
12 Ratings

About

A podcast about the practical decisions behind growing a business in Southern California — capital, hiring, partnerships, exits, and leadership.